References
- Valentine JS. Do oxidatively modified proteins cause ALS? Free Radic Biol Med 2002; 33(10): 1314–1320.
- Kopito RR. Aggresomes, inclusion bodies and protein aggrega- tion. Trends Cell Biol 2000; 10(12): 524–530.
- Bence NF, Sampat RM, Kopito RR. Impairment of the ubiquitin- proteasome system by protein aggregation. Science 2001; 292(5521): 1552–1555.
- Johnston JA, Dalton MJ, Gurney ME, Kopito RR. Formation of high molecular weight complexes of mutant Cu/Zn-superoxide dismutase in a mouse model for familial amyotrophic lateral sclerosis. Proc Natl Acad Sci U S A 2000; 97(23): 12571–12576.
- Bruijn LI, Houseweart MK, Kato S et al. Aggregation and motor neuron toxicity of an ALS-linked SOD1 mutant independent from wild-type SOD1. Science 1998; 281(5384): 1851–1854.
- Shibata N, Hirano A, Kobayashi M et al. Cu/Zn superoxide dismutase-like immunoreactivity in Lewy body-like inclusions of sporadic amyotrophic lateral sclerosis. Neurosci Lett 1994; 179(1–2): 149–152.
- Liu J, Cleveland DW. ALS-linked SOD1 mutants mislocalise HSP70 into aggregates but these do not alter the course of disease. Soc Neurosci abstr 2001; 2001 San Diego, USA: 580.3.
- Rakhit R, Cunningham P, Furtos-Matei A et al. Oxidation- induced misfolding and aggregation of superoxide dismutase and its implications for amyotrophic lateral sclerosis. J Biol Chem 2002; 277(49): 47551–47556.
- Meng L, Mohan R, Kwok BH, Elofsson M, Sin N, Crews CM. Epoxomicin, a potent and selective proteasome inhibitor, exhibits in vivo anti-inflammatory activity. Proc Natl Acad Sci U S A 1999; 96(18): 10403–10408.
- Kaal EC, Vlug AS, Versleijen MW, Kuilman M, Joosten EA, Bar PR. Chronic mitochondrial inhibition induces selective motor neuron death in vitro: a new model for amyotrophic lateral sclerosis. J Neurochem 2000; 74(3): 1158–1165.
- Jaarsma D, Rognoni F, van Duijn W, Verspaget HW, Haasdijk ED, Holstege JC. Cu/Zn superoxide dismutase (SOD1) accumu- lates in vacuolated mitochondria in transgenic mice expressing amyotrophic lateral sclerosis-linked SOD1 mutations. Acta Neuropathol (Berl) 2001; 102(4): 293–305.
- Kozlowski L, Stoklosa T, Omura S et al. Lactacystin inhibits cathepsin A activity in melanoma cell lines. Tumour Biol 2001; 22(4): 211–215.
- Cleveland DW, Rothstein JD. From Charcot to Lou Gehrig: deciphering selective motor neuron death in ALS. Nat Rev Neurosci 2001; 2(11): 806–819.
- Kikuchi S, Shinpo K, Takeuchi M et al. Effect of geranylaceton on cellular damage induced by proteasome inhibition in cultured spinal neurons. J Neurosci Res 2002; 69(3): 373–381.
- Ding Q, Keller JN. Proteasomes and proteasome inhibition in the central nervous system. Free Radic Biol Med 2001; 31(5): 574–584.
- Sadoul R, Fernandez PA, Quiquerez AL et al. Involvement of the proteasome in the programmed cell death of NGF-deprived sympathetic neurons. Embo J 1996; 15(15): 3845–3852.
- Yang Y, Yu X. Regulation of apoptosis: the ubiquitous way. Faseb J 2003; 17(8): 790–799.
- Forman MS, Lee VM-Y, Trojanowski JQ. ‘Unfolding’ pathways in neurodegenerative disease. Trends Neurosci 2003; 26(8): 407–410.
- Hyun DH, Lee M, Halliwell B, Jenner P. Proteasomal inhibition causes the formation of protein aggregates containing a wide range of proteins, including nitrated proteins. J Neurochem 2003; 86(2): 363–373.
- Watanabe M, Dykes-Hoberg M, Culotta VC, Price DL, Wong PC, Rothstein JD. Histological evidence of protein aggregation in mutant SOD1 transgenic mice and in amyotrophic lateral sclerosis neural tissues. Neurobiol Dis 2001; 8(6): 933–941.
- Shibata N, Nagai R, Uchida K et al. Morphological evidence for lipid peroxidation and protein glycoxidation in spinal cords from sporadic amyotrophic lateral sclerosis patients. Brain Res 2001; 917(1): 97–104.